Avanos Medical, Inc.

AVNS · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1-$77$7-$397
Dep. & Amort.$9$10$10$11
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$4$4$4
Change in WC-$3-$7$5$45
Other Non-Cash$9$76$0$395
Operating Cash Flow$14$7$26$58
Investing Activities
PP&E Inv.-$7-$11-$7-$5
Net Acquisitions$0-$2-$2$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$25$0$0-$3
Investing Cash Flow-$32-$13-$9-$8
Financing Activities
Debt Repay.-$2-$2-$27-$27
Stock Issued$0$0$0$0
Stock Repurch.$0-$1-$2-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$2-$3-$29-$27
Forex Effect-$0$3$2-$4
Net Chg. in Cash-$20-$7-$11$19
Supplemental Information
Beg. Cash$90$97$108$89
End Cash$71$90$97$108
Free Cash Flow$7-$4$19$53